We are live on ! Find out more
GCGM

General Catalyst Group Management Portfolio holdings

AUM $184M
1-Year Est. Return 50.45%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+50.45%
3 Year Est. Return
+205.57%
5 Year Est. Return
+78.87%
10 Year Est. Return
AUM
$1.09B
AUM Growth
-$37.3M
Cap. Flow
-$46.9M
Cap. Flow %
-4.32%
Top 10 Hldgs %
95.41%
Holding
16
New
1
Increased
1
Reduced
2
Closed
1

Top Sells

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$57.9M
2
TDOC icon
Teladoc Health
TDOC
+$19.3M
3
LMND icon
Lemonade
LMND
+$15.9M

Sector Composition

Rank Sector Weight
1 Technology 69.8%
2 Healthcare 13.61%
3 Financials 12.54%
4 Industrials 2.6%
5 Consumer Discretionary 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOT icon
1
Samsara
IOT
$22.8B
$572M 52.76%
47,428,587
GTLB icon
2
GitLab
GTLB
$5.84B
$109M 10.01%
2,121,405
-991,500
-32% -$57.9M
CPAR
3
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$76.2M 7.02%
7,714,286
WRBY icon
4
Warby Parker
WRBY
$3.21B
$75.5M 6.95%
5,656,571
OSCR icon
5
Oscar Health
OSCR
$9.26B
$72.2M 6.65%
14,464,995
XM
6
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
$44.2M 4.07%
4,337,186
EVLV icon
7
Evolv Technologies
EVLV
$1.01B
$28.2M 2.6%
13,296,148
HAAC
8
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$23.1M 2.13%
2,311,624
CMRC
9
Commerce.com Inc Series 1
CMRC
$269M
$17.8M 1.64%
1,200,000
LMND icon
10
Lemonade
LMND
$3.73B
$17.1M 1.57%
806,722
-700,000
-46% -$15.9M
CZOO
11
DELISTED
Cazoo Group Ltd
CZOO
$15.8M 1.46%
17,213
PET
12
DELISTED
Wag!
PET
$14.3M 1.32%
+6,976,530
New +$45.6M
REVH
13
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
$12M 1.11%
1,223,750
+53,125
+5% +$521K
OPRT icon
14
Oportun Financial
OPRT
$264M
$4.13M 0.38%
944,556
VRM icon
15
Vroom Inc
VRM
$37.5M
$3.54M 0.33%
38,146
TDOC icon
16
Teladoc Health
TDOC
$1.67B
-581,347
Closed -$19.3M

Similar funds

General Catalyst Group Management's Q3 2022 Portfolio in Review

As of Q3 2022, General Catalyst Group Management held 16 positions worth $1.09B, down 3.3% from $1.12B the previous quarter. Its ten largest holdings account for 95% of the portfolio.

General Catalyst Group Management withdrew a net $46.9M in Q3 2022, closing 1 position and reducing 2 holdings. Its most notable exit was Teladoc Health, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 70% of assets, up from 69% a quarter earlier, followed by Healthcare and Financials.

Against the trend, General Catalyst Group Management opened a new position in Wag! worth $14.3M.

  • General Catalyst Group Management's largest Q3 2022 buy was Wag!: 6,976,530 shares worth $14.3M.
  • General Catalyst Group Management added most to Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q3 2022, an estimated $521K increase.
  • General Catalyst Group Management's biggest Q3 2022 reduction was GitLab, cutting an estimated $57.9M.
  • General Catalyst Group Management fully exited Teladoc Health in Q3 2022, selling an estimated $19.3M.
  • General Catalyst Group Management's ten largest holdings make up 95% of its $1.09B portfolio in Q3 2022.
  • General Catalyst Group Management opened 1 new position and closed 1 in Q3 2022.
  • General Catalyst Group Management's portfolio value fell 3.3% quarter-over-quarter to $1.09B.

Based on General Catalyst Group Management's 13F filing for Q3 2022, filed 9 Nov 2022.